Dr. Richard Lazzaro performing robotic pulmonary lobectomy.
In this video from the National Comprehensive Cancer Network (NCCN), lung cancer expert David Ettinger, MD, from the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, explains targeted or genetically based therapy in lung cancer. The NCCN is a not-for-profit alliance of 21 leading cancer centers—including the Sidney Kimmel Comprehensive Cancer Center —dedicated to improving care for cancer patients. For more free information on lung cancer, including the NCCN Guidelines for Patients , visit www.NCCN.com.
Lung cancer is tumor arising from cells lining the airways of the respiratory system. Adenocarcinoma of the lung is one of the major kinds of cancers of lung, accounting for 32% of all cases of the disease. It arises from the secretory cells found in the epithelium lining the bronchi.
The progression of adenocarcinoma is fairly unpredictable. In nearly all cases, adenocarcinoma spreads slowly and leads to very few lung cancer symptoms. But it can also be very invasive, aggressively spreading by way of the body and causing fatality before it can be treated.
Its symptoms may consist of shortness of breath, the coughing up of blood, chest pains, fatigue, and unexplained weight loss. Adenocarcinoma is typically treated with lung cancer surgery, radiation therapy, and chemotherapy.
From the 1950s, the occurrence of lung adenocarcinoma started to rise relative to other kinds of lung cancer. This is partially because of the introduction of filter cigarettes. The usage of filters removes larger particles from tobacco smoke, hence reducing deposition in larger airways.
Most of this kind of cancer is found in smokers. However, it is the most common type of cancer of lung seen in nonsmokers as well. It is most frequent seen in women and people younger than 45. However, you are more likely to get adenocarcinoma if you: smoke cigarettes, breathe cigarette smoke, exposed to radon gas, exposed to asbestos, exposed to other carcinogens in the workplace.
Even if generally connected with lung cancer, adenocarcinoma is a kind of cancer that develops in cells lining glandular kinds of internal organs, like the lungs, colon, stomach, breasts, prostate, pancreas, and cervix. Another kind of adenocarcinoma, mucinous adenocarcinoma, accounts for simply 10-15% of all adenocarcinomas and is particular to aggressive carcinomas that are comprised of at least sixty percent mucus.
In order to overcome this deadly disease the doctor and the patient has to work as a team to fight the battle against this awful disease.
If you want to get some excellent resources, please visit my site on 1st-on-LungCancer or Adenocarcinoma Lung Cancer.
Article Source: http://EzineArticles.com/?expert=David_Smidev
Related articles by Cancer Treatment Pro
- Men Who Eat Soy May Have Lower Lung Cancer Risk (nlm.nih.gov)
- Lung Cancer Most Common Symptoms (livingstrongandhappy.blogspot.com)
- #AACR lung cancer meeting report: ELM4-ALK inhibitors (pharmastrategyblog.com)








Dr. Ernest Cohn, MD: "This book is by far the most complete and accurate review of alternative therapies I’ve seen in the 30+ years of my practice. I recommend our patients read this book now before we accept them for care here. It can save a patient’s life."
Dr.Pavel Yakovlev, MD: "The material in this book is enriching and hope-giving for clinical practice. I like the way you finish your book, with a notion of spiritual cancer, which is very important to remember when dealing with the patient."
Dr. Rashid Buttar: "I plan on recommending it to all my patients suffering from cancer who seek treatment at our clinic so that the light of truth and hope contained within this book can shine brightly on them as well."